0001493152-23-044430.txt : 20231211
0001493152-23-044430.hdr.sgml : 20231211
20231211171840
ACCESSION NUMBER: 0001493152-23-044430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231207
FILED AS OF DATE: 20231211
DATE AS OF CHANGE: 20231211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coste Catherine
CENTRAL INDEX KEY: 0001821432
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37863
FILM NUMBER: 231478996
MAIL ADDRESS:
STREET 1: 966 OCHO RIOS DR
CITY: DANVILLE
STATE: CA
ZIP: 94526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMERICA INC
CENTRAL INDEX KEY: 0000073290
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 952645573
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 17571 VON KARMAN AVENUE
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9493792875
MAIL ADDRESS:
STREET 1: 17571 VON KARMAN AVENUE
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: NMS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19871130
FORMER COMPANY:
FORMER CONFORMED NAME: NUCLEAR MEDICAL SYSTEMS INC
DATE OF NAME CHANGE: 19830216
FORMER COMPANY:
FORMER CONFORMED NAME: NUCLEAR INSTRUMENTS INC
DATE OF NAME CHANGE: 19720508
4
1
ownership.xml
X0508
4
2023-12-07
0
0000073290
BIOMERICA INC
BMRA
0001821432
Coste Catherine
17571 VON KARMAN AVE
IRVINE
CA
92614
1
0
0
0
0
Common stock
43790
D
Non-qualified stock option
1.67
2023-04-20
4
A
0
32000
A
2023-12-07
2033-04-20
Common Stock
32000
32000
D
Options granted to Ms. Coste in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023.
Not Applicable
/s/ Catherine Coste
2023-12-11